[HTML][HTML] European best practice guidelines for cystic fibrosis neonatal screening

…, M Ballmann, C Corbetta, I de Monestrol… - Journal of Cystic …, 2009 - Elsevier
There is wide agreement on the benefits of NBS for CF in terms of lowered disease severity,
decreased burden of care, and reduced costs. Risks are mainly associated with disclosure …

[HTML][HTML] The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

…, P Poli, A Amato, G Ferrari, K de Winter-de Groot… - Journal of cystic …, 2020 - Elsevier
With the growing SARS-CoV-2 pandemic, we need to better understand its impact in specific
patient groups like those with Cystic Fibrosis (CF). We report on 181 people with CF (32 …

[HTML][HTML] Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: an international observational study

…, J Melo, P Mondejar-Lopez, I de Monestrol… - Journal of Cystic …, 2021 - Elsevier
Background The presence of co-morbidities, including underlying respiratory problems, has
been identified as a risk factor for severe COVID-19 disease. Information on the clinical …

[HTML][HTML] Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis–data from the European cystic fibrosis society patient registry

…, U Krivec, C Vazquez-Cordero, I de Monestrol… - Journal of Cystic …, 2020 - Elsevier
Background Monitoring changes in the epidemiology of cystic fibrosis (CF) pathogens is
essential for clinical research, quality improvement, and clinical management. Methods We …

[HTML][HTML] Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020

…, U Krivecs, P Mondejar-Lopez, I de Monestrol… - Journal of cystic …, 2021 - Elsevier
… ), Brussels, Belgium & Institut de mucoviscidose de l'université libre de Bruxelles (ULB),
hôpital … de Monestrol reports grants from Vertex, outside the submitted work; Dr. Lindblad has …

Mutations in the amiloride‐sensitive epithelial sodium channel in patients with cystic fibrosis‐like disease

…, M Schwarz, V Skalicka, I De Monestrol… - Human …, 2009 - Wiley Online Library
We investigated whether mutations in the genes that code for the different subunits of the
amiloride‐sensitive epithelial sodium channel (ENaC) might result in cystic fibrosis (CF)‐like …

[HTML][HTML] Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe

…, EF McKone, M Mei-Zahav, I de Monestrol… - ERJ open …, 2021 - Eur Respiratory Soc
de Monestrol reports grant from Vertex for an academic research study regarding
gastrointestinal outcome in CF patients taking Orkambi medication, outside the submitted work; …

Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

…, C Gunaratnam, A Jackson, K de Winter-de Groot… - Journal of Cystic …, 2022 - Elsevier
Background This international study aimed to characterise the impact of acute SARS-CoV-2
infection in people with cystic fibrosis and investigate factors associated with severe …

Ursodeoxycholic acid and liver disease associated with cystic fibrosis: a multicenter cohort study

…, R Padoan, I Asherova, H Evans, I de Monestrol… - Journal of Cystic …, 2022 - Elsevier
Background The efficacy and safety of ursodeoxycholic acid (UDCA) for the treatment of
liver disease associated with cystic fibrosis (CF) are under discussion, and clinical practice …

Experiences of individuals awaiting lung transplantation

U Skogeland, I de Monestrol, TE Godskesen - Respiratory care, 2018 - rc.rcjournal.com
Lung transplantation is an established intervention for patients with advanced and life-threatening
respiratory disease. Unfortunately, the shortage of organ donors results in a need for …